Dr. Tremoulet graduated from Harvard University with a major in Biochemistry and then attended medical school at the University of California, Los Angeles. During medical school, she completed a fellowship at the National Institutes of Health as a Clinical Research Training Program fellow. She then completed her pediatric infectious disease fellowship at the University of California, San Diego, and joined the faculty in 2006 where she is now an Associate Professor in the Division of Host-Microbe Systems and Therapeutics in the Department of Pediatrics. In 2007, Dr. Tremoulet became the Associate Director of the Kawasaki Disease (KD) Research Center at the University of California, San Diego. In this capacity she cares for nearly 1300 children with KD in San Diego County and an additional 100 children annually hospitalized at Rady Children’s Hospital San Diego with KD. She has a passion for pediatric pharmacology and serves as the co-principal investigator of the NIH-funded UC San Diego Research Program in Developmental Pharmacology as well as Co-Director of the UC San Diego Department of Pediatric Clinical Pharmacology Training Program. She leads Phase I through III clinical trials including an FDA Orphan Products Grant funded Phase III clinical trial on the use of infliximab as adjunctive primary therapy in KD as well as Phase I/IIa clinical trials of atorvastatin and anakinra in children with KD and coronary artery damage. Her research interest lies in the interface between pediatric pharmacology and the repurposing of therapies for use in pediatric inflammatory and infectious diseases.